US Patent 11987617 Antibodies that target HIV GP120 and methods of use
Patent 11987617 was granted and assigned to Gilead Sciences on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+41 properties)
Article (+223 characters)
US Patent 11987617 Antibodies that target HIV GP120 and methods of use
Article
Patent abstract
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Brian A. Carr0
Doug Rehder0
Loredana Serafini0
Magdeleine S. Hung0
Manu Kanwar0
Matthew Robert Schenauer0
Mini Balakrishnan0
Nathan D. Thomsen0
Date of Patent
May 21, 2024
0Patent Application Number
183658690
Date Filed
August 4, 2023
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11987617 Antibodies that target HIV GP120 and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
